Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06444126
Status:
RECRUITING
Last Update Posted:
2024-06-10
First Post:
2024-05-30
Brief Title:
The Incidence And Risk Factors Of Recurrent Febrile Seizures And Epilepsy Following Febrile Seizures
Sponsor:
Pham Ngoc Thach University of Medicine
Organization:
Pham Ngoc Thach University of Medicine
Study Overview
Official Title:
A Prospective Cohort Study Of The Incidence And Risk Factors Of Recurrent Febrile Seizures And Epilepsy Following Febrile Seizures
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to learn about the recurrence and development of epilepsy in children hospitalized with their first febrile seizures The main questions it aims to answer are
What is the risk of recurrence after the first febrile seizure and what are the risk factors for recurrent febrile seizures in Vietnamese children
What is the risk of developing epilepsy later in life and what are the risk factors for developing epilepsy in Vietnamese children who have had febrile seizures
What is the risk of recurrence after the first febrile seizure and what are the risk factors for recurrent febrile seizures in Vietnamese children
What is the risk of developing epilepsy later in life and what are the risk factors for developing epilepsy in Vietnamese children who have had febrile seizures
Detailed Description:
This was a single-center longitudinal cohort study Vietnamese children were prospectively identified for their first febrile seizures FS through the General Pediatric Department and Neurology Department of Childrens Hospital 2 in Ho Chi Minh City between March and December 2023 This hospital is one of the largest tertiary pediatric hospitals in southern Vietnam with 1400 beds and receives about 90000 admissions every year with 800-1000 cases of initial FS After recruitment the participants have been monitored for an average of two years to determine whether they experience recurring FS or develop epilepsy
Sample size and sampling
The sample size was calculated using a specific formula to estimate the incidence of FS recurrence in the cohort study With the desired confidence level of 95 an estimated error of 01 and an expected incidence of 318 based on a similar study conducted by Berg the minimum sample size required was determined to be 385 participants The sample size was also estimated based on the number of events per predictor in regression models with at least 10 events per predictor recommended by Peduzzi et al For the recurrent FS outcome we have 12 potential predictor variables including age of onset male gender prematurity low birth weight neurodevelopmental abnormality family history of FS or epilepsy temperature duration of fever at the time of the seizure and characteristic of the first FS such as semiology duration and number of seizures during the illness yielding approximately 120 cases to achieve the required sample size for estimating recurrence of FS Besides that we also have 16 potential predictor variables for the subsequent epilepsy outcome including the above factors adding to the number of FS and characteristics of all FS first and recurrences As such we aimed to obtain at least 160 children Finally the overall sample size required at least 385 patients
Convenience sampling was applied to recruit the participants In detail every weekday the list of inpatient reports of the General Pediatric Department and Neurology Department on the electronic medical record database of Childrens Hospital 2 was used to identify all children who had been diagnosed with FS and admitted to these departments The investigator met with these childrens parents or caregivers and asked a series of screening questions to confirm that they had not previously experienced febrile or unprovoked seizures If the child had such a history they were excluded from the study The patients were then followed up until they recovered and were discharged from the hospital At this point the investigator made the final diagnosis of the first FS and assessed whether any exclusion criteria applied If the patients were eligible for the study the investigator obtained informed consent from their parents and proceeded to gather study data
Data collection
The standardized questionnaire solicited child-related data including the age of onset gender perinatal history ie age of gestation birth weight asphyxia hospitalization at the neonatal intensive care unit medical history previous neurological diseases family history of FS and epilepsy including first relative and any relative seizure-related data including semiology duration and number of seizures during the illness and illness-related data including temperature duration of fever at the time of the seizure and the cause of fever The interviewer obtained a comprehensive description of the seizure from either the parent or if unavailable from an eyewitness Descriptions were compiled from both medical records and interviews and additional clarification was sought if necessary by contacting the parent or witness again Particular note was taken of the presence of asymmetrical features involving a unilateral arm leg or face or some combination or an eye deviation to one side even if the fit later became bilateral tonic-clonic Those seizures were classified as focal-onset seizures according to the ILAE classification in 2017 The presence of Todds paresis paralysis of one limb or one side of the body or a gaze palsy in the immediate postictal period was considered indicative of a focal seizure The study used medical records to gather information on seizures associated symptoms diagnosis and temperature
At the time of the first FS a detailed neurologic examination and Denver II developmental screening test were conducted by a pediatrician Test Denver II is a scale to assess the psychomotor development of children under 6 years old which is validated and used in clinical practice in Vietnam Test Denver II is a fairly comprehensive assessment of child development and focuses on 4 areas personal-social fine motor-adaptive language and gross motor The interpretation of the test results indicates an obvious developmental delay if there are delayed items in at least two areas with each area having a minimum of two items A child is considered to have a suspected developmental delay if there are delayed items in one area with at least two items If there are no signs of suspected or delayed development as described above the child is considered normal Developmental Quotient DQ is a calculation that reflects the rate of development in any given area and represents the percentage of normal development present at the time of testing
Developmental Quotient DQ Developmental age DAChronological age CA x 100
Lumbar puncture was performed only in cases that were indicative of meningitis or encephalitis whereas neuroimaging computerized tomography CT or magnetic resonance imaging MRI was performed on children with focal seizures febrile status epilepticus or abnormal neurologic examination Children who experience their first FS in our setting usually do not undergo an electroencephalography EEG
Following the initial interview parents were contacted every three months to determine whether their child had experienced any further seizures and the circumstances under which they occurred If a febrile seizure recurs or an afebrile seizure occurs parents can report it immediately and directly to the investigator Descriptions of the recurrent seizures were obtained in the same manner as for the initial FS Whenever possible we also obtained documentation of the recurrence from the medical record Our goal was to follow children for an average of two years from the initial FS We considered a seizure unprovoked if there were no acute precipitating circumstances to which the seizure could reasonably be attributed According to the ILAE practical clinical definition from 2014 epilepsy is characterized by having two unprovoked seizures that are more than 24 hours apart Children were censored from further analysis if they experienced an unprovoked seizure or were lost to follow-up
Ethical considerations
The study protocol was approved by the Ethical Committee of Childrens Hospital 2 124 GCN-BVNĐ2 and written consent was obtained from all participants Informed consent was obtained from all study participants and their parentscaregivers
Sample size and sampling
The sample size was calculated using a specific formula to estimate the incidence of FS recurrence in the cohort study With the desired confidence level of 95 an estimated error of 01 and an expected incidence of 318 based on a similar study conducted by Berg the minimum sample size required was determined to be 385 participants The sample size was also estimated based on the number of events per predictor in regression models with at least 10 events per predictor recommended by Peduzzi et al For the recurrent FS outcome we have 12 potential predictor variables including age of onset male gender prematurity low birth weight neurodevelopmental abnormality family history of FS or epilepsy temperature duration of fever at the time of the seizure and characteristic of the first FS such as semiology duration and number of seizures during the illness yielding approximately 120 cases to achieve the required sample size for estimating recurrence of FS Besides that we also have 16 potential predictor variables for the subsequent epilepsy outcome including the above factors adding to the number of FS and characteristics of all FS first and recurrences As such we aimed to obtain at least 160 children Finally the overall sample size required at least 385 patients
Convenience sampling was applied to recruit the participants In detail every weekday the list of inpatient reports of the General Pediatric Department and Neurology Department on the electronic medical record database of Childrens Hospital 2 was used to identify all children who had been diagnosed with FS and admitted to these departments The investigator met with these childrens parents or caregivers and asked a series of screening questions to confirm that they had not previously experienced febrile or unprovoked seizures If the child had such a history they were excluded from the study The patients were then followed up until they recovered and were discharged from the hospital At this point the investigator made the final diagnosis of the first FS and assessed whether any exclusion criteria applied If the patients were eligible for the study the investigator obtained informed consent from their parents and proceeded to gather study data
Data collection
The standardized questionnaire solicited child-related data including the age of onset gender perinatal history ie age of gestation birth weight asphyxia hospitalization at the neonatal intensive care unit medical history previous neurological diseases family history of FS and epilepsy including first relative and any relative seizure-related data including semiology duration and number of seizures during the illness and illness-related data including temperature duration of fever at the time of the seizure and the cause of fever The interviewer obtained a comprehensive description of the seizure from either the parent or if unavailable from an eyewitness Descriptions were compiled from both medical records and interviews and additional clarification was sought if necessary by contacting the parent or witness again Particular note was taken of the presence of asymmetrical features involving a unilateral arm leg or face or some combination or an eye deviation to one side even if the fit later became bilateral tonic-clonic Those seizures were classified as focal-onset seizures according to the ILAE classification in 2017 The presence of Todds paresis paralysis of one limb or one side of the body or a gaze palsy in the immediate postictal period was considered indicative of a focal seizure The study used medical records to gather information on seizures associated symptoms diagnosis and temperature
At the time of the first FS a detailed neurologic examination and Denver II developmental screening test were conducted by a pediatrician Test Denver II is a scale to assess the psychomotor development of children under 6 years old which is validated and used in clinical practice in Vietnam Test Denver II is a fairly comprehensive assessment of child development and focuses on 4 areas personal-social fine motor-adaptive language and gross motor The interpretation of the test results indicates an obvious developmental delay if there are delayed items in at least two areas with each area having a minimum of two items A child is considered to have a suspected developmental delay if there are delayed items in one area with at least two items If there are no signs of suspected or delayed development as described above the child is considered normal Developmental Quotient DQ is a calculation that reflects the rate of development in any given area and represents the percentage of normal development present at the time of testing
Developmental Quotient DQ Developmental age DAChronological age CA x 100
Lumbar puncture was performed only in cases that were indicative of meningitis or encephalitis whereas neuroimaging computerized tomography CT or magnetic resonance imaging MRI was performed on children with focal seizures febrile status epilepticus or abnormal neurologic examination Children who experience their first FS in our setting usually do not undergo an electroencephalography EEG
Following the initial interview parents were contacted every three months to determine whether their child had experienced any further seizures and the circumstances under which they occurred If a febrile seizure recurs or an afebrile seizure occurs parents can report it immediately and directly to the investigator Descriptions of the recurrent seizures were obtained in the same manner as for the initial FS Whenever possible we also obtained documentation of the recurrence from the medical record Our goal was to follow children for an average of two years from the initial FS We considered a seizure unprovoked if there were no acute precipitating circumstances to which the seizure could reasonably be attributed According to the ILAE practical clinical definition from 2014 epilepsy is characterized by having two unprovoked seizures that are more than 24 hours apart Children were censored from further analysis if they experienced an unprovoked seizure or were lost to follow-up
Ethical considerations
The study protocol was approved by the Ethical Committee of Childrens Hospital 2 124 GCN-BVNĐ2 and written consent was obtained from all participants Informed consent was obtained from all study participants and their parentscaregivers
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None